张平;徐颖华;侯启明;张庶民;

• 1:中国食品药品检定研究院百白破疫苗和毒素室 卫生部生物技术产品检定方法及其标准化重点实验室

摘要(Abstract)：

近年来,随着研究的深入,特异性细胞免疫在百日咳感染和疫苗诱导的免疫保护等方面的作用越来越引起人们的重视。本文就百日咳杆菌主要毒力因子在诱导细胞免疫及免疫调节中的作用、百日咳感染及疫苗免疫接种后诱导产生的细胞免疫应答等方面的研究进展作一综述。

关键词(KeyWords)： 百日咳;细胞免疫;免疫调节

Abstract:

Keywords:

基金项目(Foundation): 国家863计划“疫苗效果和质量评价新技术研究”(2012-AA02A402)

作者(Authors): 张平;徐颖华;侯启明;张庶民;

DOI: 10.13200/j.cjb.2013.07.138.zhangp.011

参考文献(References)：

• [1]Tomovici A,Barreto L,Zickler P,et al.Humoral immunity 10years after booster immunization with an adolescent and adultformulation combined tetanus,diphtheria,and 5-componentacellular pertussis vaccine[J].Vaccine,2012,30(16):2647-2653.
• [2]Saito R,Kamachi K.Bordetella pertussis[J].Nihon Rinsho,2010,68(Suppl 6):189-192.
• [3]Meyer CU,Zepp F,Decker M,et al.Cellular immunity inadolescents and adults following acellular pertussis vaccineadministration[J].Clin Vaccine Immunol,2007,14(3):288-292.
• [4]Locht C,Coutte L,Mielcarek N.The ins and outs of pertussistoxin[J].FEBS J,2011,278(23):4668-4682.
• [5]Martino A,Volpe E,Auricchio G,et al.Influence of pertussistoxin on CD1a isoform expression in human dendritic cells[J].J Clin Immunol,2006,26(2):153-159.
• [6]Mills KH.Immunity to Bordetella pertussis[J].Microbes Infect,2001,3(8):655-677.
• [7]Murphey C,Chang S,Zhang X,et al.Induction of polyclonalCD8+T cell activation and effector function by Pertussis toxin[J].Cell Immunol,2011,267(1):50-55.
• [8]Andreasen C,Powell DA,Carbonetti NH.Pertussis toxinstimulates IL-17 production in response to Bordetella pertussisinfection in mice[J].PloS One,2009,4(9):e7079.
• [9]Serra DO,Conover MS,Arnal L,et al.FHA-mediated cell-substrate and cell-cell adhesions are critical for Bordetella per-tussis biofilm formation on abiotic surfaces and in the mousenose and the trachea[J].PLoS One,2011,6(12):e28811.
• [10]Dieterich C,Relman DA.Modulation of the host interferonresponse and ISGylation pathway by B.pertussis filamentoushemagglutinin[J].PLoS One,2011,6(11):e27535.
• [11]Bumba L,Masin J,Fiser R,et al.Bordetella adenylate cyclasetoxin mobilizes its beta2 integrin receptor into lipid rafts toaccomplish translocation across target cell membrane in twosteps[J].PLoS Pathog,2010,6(5):e1000901.
• [12]Boyd AP,Ross PJ,Conroy H,et al.Bordetella pertussis adeny-late cyclase toxin modulates innate and adaptive immune res-ponses:distinct roles for acylation and enzymatic activity inimmunomodulation and cell death[J].J Immunol,2005,175(2):730-738.
• [13]Martín C,Uribe KB,Gómez-Bilbao G,et al.Adenylate cyclasetoxin promotes internalisation of integrins and raft componentsand decreases macrophage adhesion capacity[J].PLoS One,2011,6(2):e17383.
• [14]Paccani SR,Finetti F,Davi M,et al.The Bordetella pertussisadenylate cyclase toxin binds to T cells via LFA-1 and inducesits disengagement from the immune synapse[J].J Exp Med,2010,208(6):1317-1330.
• [15]Rossi Paccani S,Benagiano M,Capitani N,et al.The adeny-late cyclase toxins of Bacillus anthracis and Bordetella pertu-ssis promote Th2 cell development by shaping T cell antigenreceptor signaling[J].PLoS Pathog,2009,5(3):e1000325.
• [16]Dunne A,Ross PJ,Pospisilova E,et al.Inflammasome activa-tion by adenylate cyclase toxin directs Th17 responses andprotection against Bordetella pertussis[J].J Immunol,2010,185(3):1711-1719.
• [17]Spensieri F,Fedele G,Fazio C,et al.Bordetella pertussisinhibition of interleukin-12(IL-12)p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylatecyclase toxin-dependent cyclic AMP induction[J].InfectImmun,2006,74(5):2831-2838.
• [18]Fedele G,Spensieri F,Palazzo R,et al.Bordetella pertussiscommits human dendritic cells to promote a Th1/Th17 responsethrough the activity of adenylate cyclase toxin and MAPK-pathways[J].PLoS One,2010,5(1):e8734.
• [19]Stenger RM,Poelen MC,Moret EE,et al.Immunodominancein mouse and human CD4+T-cell responses specific for theBordetella pertussis virulence factor P.69 pertactin[J].InfectImmun,2009,77(2):896-903.
• [20]Xing DK,Canthaboo C,Corbel MJ.Effect of pertussis toxin onthe induction of nitric oxide synthesis in murine macrophagesand on protection in vivo[J].Vaccine,2000,18(20):2110-2119.
• [21]Mills KH,Barnard A,Watkins J,et al.Cell-mediated immunityto Bordetella pertussis:role of Th1 cells in bacterial clearancein a murine respiratory infection model[J].Infect Immun,1993,61(2):399-410.
• [22]Ausiello CM,Lande R,Stefanelli P,et al.T-cell immuneresponse assessment as a complement to serology and intrana-sal protection assays in determining the protective immunityinduced by acellular pertussis vaccines in mice[J].Clin DiagnLab Immunol,2003,10(4):637-642.
• [23]Bromberg K,Tannis G,Steine P.Detection of Bordetella pertu-ssis associated with the alveolar macrophages of children withhuman immunodeficiency virus infection[J].Infect Immun,1991,59(12):4715-4719.
• [24]Carollo M,Palazzo R,Bianco M,et al.Antigen-specific respo-nses assessment for the evaluation of Bordetella pertussis Tcell immunity in humans[J].Vaccine,2012,30(9):1667-1674.
• [25]Higgs R,Higgins SC,Ross PJ,et al.Immunity to the respira-tory pathogen Bordetella pertussis[J].Mucosal Immunol,2012,5(5):485-500.
• [26]Ryan EJ,Nilsson L,Kjellman N,et al.Booster immunization ofchildren with an acellular pertussis vaccine enhances Th2cytokine production and serum IgE responses against pertussistoxin but not against common allergens[J].Clin Exp Immunol,2000,121(2):193-200.
• [27]Vermeulen F,Verscheure V,Damis E,et al.Cellular immuneresponses of preterm infants after vaccination with whole-cellor acellular pertussis vaccines[J].Clin Vaccine Immunol,2010,17(2):258-262.
• [28]Dirix V,Verscheure V,Goetghebuer T,et al.Cytokine andantibody profiles in 1-year-old children vaccinated with eitheracellular or whole-cell pertussis vaccine during infancy[J].Vaccine,2009,27(43):6042-6047.
• [29]Higgins SC,Jarnicki AG,Lavelle EC,et al.TLR4 mediatesvaccine-induced protective cellular immunity to Bordetellapertussis:role of IL-17-producing T cells[J].J Immunol,2006,177(11):7980-7989.
• [30]Banus S,Stenger RM,Gremmer ER,et al.The role of Toll-likereceptor-4 in pertussis vaccine-induced immunity[J].BMCImmunol,2008,9(1):21-35.
• [31]Ausiello CM,Lande R,Urbani F,et al.Cell-mediated immuneresponses in four-year-old children after primary immunizationwith acellular pertussis vaccines[J].Infect Immun,1999,67(8):4064-4071.
• [32]Zawadka M,Lutyńska A.Immunogenicity and reactogenicity ofacellular pertussis vaccines intended for adolescent and adults[J].Przegl Epidemiol,2012,66(1):99-105.
• [33]Rieber N,Graf A,Hartl D,et al.Acellular pertussis booster inadolescents induces Th1 and memory CD8+T cell immuneresponse[J].PLoS One,2011,6(3):e17271.
• [34]Edelman KJ,He Q,Makinen JP,et al.Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years afterbooster immunization with acellular pertussis vaccine[J].ClinInfect Dis,2004,39(2):179-185.
• [35]Feunou PF,Ismaili J,Debriea AS,et al.Genetic stability ofthe live attenuated Bordetella pertussis vaccine candidateBPZE1[J].Vaccine,2008,26(45):5722-5727.
• [36]Skerry CM,Mahon BP.A live,attenuated Bordetella pertussisvaccine provides long-term protection against virulentchallenge in a murine model[J].Clin Vaccine Immunol,2011,18(2):187-193.
• [37]Mielcarek N,Debrie AS,Mahieux S,et al.Dose response ofattenuated Bordetella pertussis BPZE1-induced protection inmice[J].Clin Vaccine Immunol,2010,17(3):317-324.
• [38]Skerry CM,Cassidy JP,English K.A live attenuated Bordetellapertussis candidate vaccine does not cause disseminatinginfection in gamma interferon receptor knockout mice[J].ClinVaccine Immunol,2009,16(9):1344-1351.
• [39]Kavanagh H,Noone C,Cahill E,et al.Attenuated Bordetellapertussis vaccine strain BPZE1 modulates allergen-inducedimmunity and prevents allergic pulmonary pathology in amurine model[J].Clin Exp Allergy,2010,40(6):933-941.
• [40]Fedele G,Bianco M,Debrie AS,et al.Attenuated Bordetellapertussis vaccine candidate BPZE1 promotes human dendriticcell CCL21-induced migration and drives a Th1/Th17 response[J].J Immunol,2011,186(9):5388-5396.
• [41]Kamachi K,Arakawa Y.Development of safer pertussis DNAvaccine expressing non-toxic C180 polypeptide of pertussistoxin S1 subunit[J].Vaccine,2007,25(6):1000-1006.
• [42]Fry SR,Chen AY,Daggard G,et al.Parenteral immunizationof mice with a genetically inactivated pertussis toxin DNAvaccine induces cell-mediated immunity and protection[J].JMed Microbiol,2008,57(Pt 1):28-35.